 |
      |
|
|
|
|
|
|
|
|
 |
 |
 |
 |
|||||||
|
If you've been diagnosed with glaucoma or ocular hypertension (elevated IOP), it's important to continue your ALPHAGAN® P therapy even if you feel fine. Remember, there are no early warning signs or symptoms. You usually can't feel the elevated IOP, and only your eye care professional can detect and measure it. Glaucoma is a lifelong disease, which means treatment is also lifelong. Remembering to take your eyedrops is easier if you make them another part of your daily routine. Committing to taking your medication exactly as prescribed is the best way to manage glaucoma, which may prevent or delay any further vision loss. You play the most important role in your treatment. The success of your therapy ultimately depends upon you and your ongoing daily commitment to take your glaucoma medication as your doctor prescribed.
|
 |
|
ALPHAGAN® P ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Important Safety Information ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% should not be used in patients receiving monoamine oxidase (MAO) inhibitor therapy. Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, ocular redness, and itching. Adverse events occurring in approximately 5% to 9% included: burning sensation, increased ocular lymph nodules, increased ocular pressure, ocular allergic reaction, dry mouth, and blurred vision. Please click here for full Prescribing Information. |
|
©2008 Allergan, Inc., Irvine, CA 92612 | ® marks owned by Allergan, Inc. |